Koninklijke Philips (PHG) Change in Receivables (2010 - 2013)
Koninklijke Philips' (PHG) quarterly Change in Receivables came in at -$721.4 million in Q4 2013, down 191.22% year-on-year from $790.8 million in Q4 2012, and down 191.22% quarter-over-quarter from -$247.7 million in Q4 2012.
Koninklijke Philips (PHG) Change in Receivables (2010 - 2013) Analysis & Trends
Koninklijke Philips' Change in Receivables history runs 4 years deep, the most recent figure standing at -$721.4 million for Q4 2013.
- On a quarterly basis, Change in Receivables fell 191.22% year-over-year to -$721.4 million in Q4 2013; TTM through Dec 2013 was -$1.7 billion, a 35.9% decrease from a year earlier, with the FY2014 full-year figure at -$63.8 million, up 90.39% from the prior year.
- Change in Receivables fell to -$721.4 million in Q4 2013 per PHG's latest filing, from -$247.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at -$147.2 million in Q3 2010 and bottomed at -$721.4 million in Q4 2013.
- The 4-year median for Change in Receivables is -$257.6 million (2012), against an average of -$330.3 million.
- Across the five-year window, Change in Receivables soared 49.64% in 2012 and slumped 191.22% in 2013, its largest moves.
- Year by year, Change in Receivables stood at -$179.3 million in 2010, then slumped by 174.42% to -$491.9 million in 2011, then surged by 49.64% to -$247.7 million in 2012, then slumped by 191.22% to -$721.4 million in 2013.
- Per Business Quant, the three latest PHG Change in Receivables figures stand at -$721.4 million (Q4 2013), -$247.7 million (Q4 2012), and -$257.6 million (Q3 2012).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 123.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -721.38 Mn |
| Dec 31, 2013 | -721.38 Mn |
| Dec 31, 2012 | -247.71 Mn |
| Dec 31, 2012 | -247.71 Mn |
| Sep 30, 2012 | -257.63 Mn |
| Sep 30, 2012 | -257.63 Mn |
| Dec 31, 2011 | -491.91 Mn |
| Dec 31, 2011 | -491.91 Mn |
| Sep 30, 2011 | -267.37 Mn |
| Sep 30, 2011 | -267.37 Mn |
| Dec 31, 2010 | -179.25 Mn |
| Dec 31, 2010 | -179.25 Mn |
| Sep 30, 2010 | -147.21 Mn |
| Sep 30, 2010 | -147.21 Mn |